Navigation Links
Disruptive Students May Not Be Able to See Their Problem
Date:12/21/2011

show supporters the statistics behind childhood vision issues.

About PediaVision

PediaVision, inventor of the Spot vision screener, is dedicated to solving the critical problem of undiagnosed vision problems and transforming the lives of thousands of children each day. Automated and objective vision screening empowers organizations in public health and private medicine to positively affect the outcomes of a child's education performance.

Supported by ophthalmologists, optometrists, scientists and leading technology innovators, the Spot vision screener is breakthrough technology and represents what vision screening should be.  For more information, including how to order Spot, please visit www.pediavision.com

 


'/>"/>
SOURCE PediaVision
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough
2. Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
3. New Polar Move Heart Rate Monitor for Students Facilitates Effective and Safe Physical Education
4. Zell Lurie Institute Awards $106,300 to University of Michigan Students Through the Michigan Business Challenge and Dare to Dream Startup Grant Program
5. Coast Career Institutes Expedited Training Program for Diagnostic Medical Sonography Helps Students Land the Highly Specialized Jobs They Seek
6. Top Business School Students From Around the World Compete for Innovative Solutions to the Global Clean Water Crisis
7. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
8. Unaware of Possibilities, Many High School-Age Students Do Not Plan to Pursue Healthcare and Science Jobs
9. Adderall a Miracle Drug to College Students
10. Blog Contest Offers Graduate Students the Chance to Win a Trip to Zambia
11. Elsevier is Meeting Todays Medical Students Needs With Online, Mobile and Print Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Inc. (NYSE: RMD ) today announced results for ... was $423.0 million, a 10 percent increase compared to the ... a constant currency basis). Net income was $91.2 million, an ... 31, 2013. Diluted earnings per share for the quarter were ...
(Date:1/22/2015)... Jan. 22, 2015  Profil Institute for Clinical Research, Inc., ... obesity, announced today a new textbook,  Translational Research Methods ... Springer, a leading global scientific publisher. The ... techniques for use in early phase clinical studies of ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/w25xpc/allergy ) has ... Allergen Source, Product & by End User - Global Forecast ... The global allergy diagnostics market is valued at $1,228.58 million ... of 12.67%, to reach $2,230.72 million by 2019. Allergy diagnostics ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3
... 16, 2011 Chimerix, Inc., a biotechnology company ... will present preliminary data for CMX001 in a ... on Antimicrobial Agents and Chemotherapy (ICAAC, Chicago – ... Associate Member of Infectious Diseases Service at Memorial ...
... Pathfinder Cell Therapy, Inc. ("Pathfinder")(OTCQB: PFND), a biotechnology company ... cell damage, today announced that effective at the start ... stock will change from SYMD to PFND.  The new ... name and has been approved by the Financial Industry ...
Cached Medicine Technology:Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 2Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 3Pathfinder Cell Therapy, Inc. Announces New Stock Ticker Symbol 2
(Date:1/22/2015)... Plainsboro, NJ (PRWEB) January 22, 2015 ... advocate and keynote speaker at the upcoming 32nd ... by ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , ... breast would have gone undetected if she had not ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Payday lending ... vulnerable communities and cause financial distress to the states ... analysts at Howard University’s Center on Race and Wealth. ... in economic activity, payday loans at the same time ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... Just in Case, Inc., the makers of,the first high ... their compacts to women,s Non-Profit Groups Nationwide. They are,CALLING ... will be,chosen to receive 100 JUST IN CASE(R) compacts ... The 10,000 compact give-away will help raise awareness ...
... RATON, Fla., Jan. 11 Breckenridge,Pharmaceutical, Inc. ... with Novartis concerning Trileptal(R) and that the ... New Drug,Application for oxcarbazepine 150mg, 300mg and ... Tablets")., Breckenridge enjoys a shared 180-day ...
... HILL People given a biological and genetics-based explanation ... to blame people with anorexia for their illness than ... Carolina at Chapel Hill study found. , This is ... Crisafulli, because it suggests that wider dissemination of information ...
... Jan. 11 Life Brokerage Partners,announces three ... Group and Nationwide. With these new additions, ... products at some of the most,exclusive national ... a,national insurance brokerage agency., New relationships ...
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ) today ... four pivotal, Phase III clinical trials of Acetavance(TM), ... these clinical,trials did not meet its primary endpoint ... intensity levels over 48 hours,compared to placebo, following ...
... NEW YORK, Jan. 10 MultiVu, PR Newswire,s ... promotion of,George DeTorres to the position of divisional ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080110/NYTH078 ) ... http://www.newscom.com/cgi-bin/prnh/20020501/NYW077LOGO ...
Cached Medicine News:Health News:Teen Pregnancy Epidemic Another Reason for Women to Carry Condoms. Just in Case, Inc. Announces 10,000 Chic Condom Compact Give-Away to Women's Non-Profits Nationwide. 2Health News:People with anorexia less likely to be blamed when biology, genetics explained 2Health News:People with anorexia less likely to be blamed when biology, genetics explained 3Health News:Life Brokerage Partners Adds New Insurance Carriers 2Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 2Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 3Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 4Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 5Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 6Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 7Health News:Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team 2Health News:Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team 3
... Apron has standard front protection. ... from the shoulders to the ... a 6" wide elastic belt. ... fit various sized individuals. Available ...
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. Shoulder pads and hanging straps are standard....
Our Wrap-Around Back Relief Apron provides front and back protection. It transfer the weight from the shoulder to the waist with the aid of a 6" wide elastic belt. Belts may be ordered in various siz...
... Vest-Skirt Combination gives you the ... Comfort enhanced by distributing 70% ... the hips leaving only 30% ... the shoulders. Freedom of movement ...
Medicine Products: